Articles Tagged With: vaccination
-
The Cost-Effectiveness of HPV Vaccination for Adults Aged 30 to 45 Years
This study evaluated the cost-effectiveness of extending the upper age limit of human papillomavirus (HPV) vaccination to age 30 to 45 years using two independent HPV microsimulation models and found that vaccinating in this age group was not cost-effective.
-
HHS, CDC Open COVID-19 Vaccination to All Age 65 Years and Older
Public health officials are opening up vaccine eligibility to a broad swath of society. This includes those 65 years of age and older and those under age 65 years with high-risk medical conditions.
-
Should Family Planning Clinics Volunteer to Vaccinate Patients?
One of the biggest challenges this spring will be to find enough trained medical staff and ambulatory sites to vaccinate hundreds of millions of people within a six- to seven-month time frame. Family planning centers might be lower on the priority list for vaccination because they serve a younger population.
-
HPV Vaccination Reduces the Risk of Invasive Cervical Cancer
In this retrospective cohort study of women in Sweden, receipt of human papillomavirus vaccination prior to age 17 years was associated with an 88% decrease in cervical cancer, and vaccination at ages 17 to 30 years was associated with a 53% decrease in cervical cancer.
-
HPV Vaccination Reduces the Risk of Invasive Cervical Cancer
In this retrospective cohort study of women in Sweden, receipt of human papillomavirus vaccination prior to age 17 years was associated with an 88% decrease in cervical cancer, and vaccination at ages 17 to 30 years was associated with a 53% decrease in cervical cancer.
-
Ethical Issues Affecting COVID-19 Vaccination
The world waits eagerly for a COVID-19 vaccine. But the supply of vaccine is unlikely to initially meet the demand. Ethical issues are important as individuals and groups are prioritized for early vaccination.
-
Rotavirus Vaccine Is Safe and Effective
Routine rotavirus vaccination of infants, when implemented broadly, is safe and is associated with reductions in diarrhea-related hospitalizations, mortality, and morbidity (such as malnutrition) in children.
-
Preventing Ebola Virus Infection
In a scientific/public health triumph, the first vaccine for the prevention of Ebola virus infection has been approved. If administered prior to 10 days after exposure, its protective efficacy is 100%.
-
Mass Flu Vaccinations Serve as Emergency Drills
Infection preventionists may one day be faced with a pandemic flu or the release of a bioterrorism agent that calls for mass vaccinations or post-exposure prophylaxis of healthcare workers. One novel way to prepare now is to stage annual flu vaccinations as an emergency drill.
-
Influenza and Pertussis Vaccines for Pregnant Women: Are We Doing Enough to Encourage Vaccination?
In this cross-sectional analysis, pregnant women disproportionately accounted for 24-34% of influenza-associated hospitalizations among women aged 15 to 44 years, and infants younger than 2 months of age comprised the highest proportion of pertussis deaths. The reasons why pregnant women did not elect recommended immunizations included not believing they were effective, not knowing they should receive Tdap every pregnancy, and being concerned that the vaccines would harm the fetus.